药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Dipipanone
Tazemetostat
Avatrombopag may decrease the excretion rate of Tazemetostat which could result in a higher serum level.
Dipipanone
Darolutamide
Avatrombopag may decrease the excretion rate of Darolutamide which could result in a higher serum level.
Dipipanone
Copanlisib
Avatrombopag may decrease the excretion rate of Copanlisib which could result in a higher serum level.
Dipipanone
Prednisolone phosphate
The excretion of Prednisolone phosphate can be decreased when combined with Avatrombopag.
Dipipanone
Relebactam
The excretion of Relebactam can be decreased when combined with Avatrombopag.
Dipipanone
Edaravone
The excretion of Edaravone can be decreased when combined with Avatrombopag.
Aminorex
Satralizumab
The serum concentration of Entrectinib can be decreased when it is combined with Satralizumab.
Aminorex
Abametapir
The serum concentration of Entrectinib can be increased when it is combined with Abametapir.
Aminorex
Rimegepant
The serum concentration of Rimegepant can be increased when it is combined with Entrectinib.
Aminorex
Ubrogepant
The serum concentration of Ubrogepant can be increased when it is combined with Entrectinib.
Aminorex
Voxelotor
The serum concentration of Entrectinib can be increased when it is combined with Voxelotor.
Aminorex
Lefamulin
Entrectinib may increase the QTc-prolonging activities of Lefamulin.
Aminorex
Sertindole
The risk or severity of QTc prolongation can be increased when Sertindole is combined with Entrectinib.
Aminorex
Selpercatinib
The risk or severity of QTc prolongation can be increased when Selpercatinib is combined with Entrectinib.
Aminorex
Encorafenib
The risk or severity of QTc prolongation can be increased when Encorafenib is combined with Entrectinib.
Aminorex
Artemether
The risk or severity of QTc prolongation can be increased when Artemether is combined with Entrectinib.
Aminorex
Inotersen
The risk or severity of QTc prolongation can be increased when Inotersen is combined with Entrectinib.
Aminorex
Aripiprazole lauroxil
The risk or severity of QTc prolongation can be increased when Aripiprazole lauroxil is combined with Entrectinib.
Aminorex
Dexverapamil
The risk or severity of QTc prolongation can be increased when Dexverapamil is combined with Entrectinib.
Aminorex
Pipemidic acid
The risk or severity of QTc prolongation can be increased when Pipemidic acid is combined with Entrectinib.